Continuous Glucose Monitoring Improves HbA1c in Type 1 Diabetes
A landmark clinical trial shows CGM users achieve significantly lower HbA1c with fewer hypoglycemic episodes compared to traditional fingerstick testing.
Continuous glucose monitors, insulin pumps, smart pens, diabetes apps, wearables, telehealth platforms, and the digital health revolution transforming diabetes management.
9 articles
A landmark clinical trial shows CGM users achieve significantly lower HbA1c with fewer hypoglycemic episodes compared to traditional fingerstick testing.
How monitoring technology has evolved from painful finger pricks to painless continuous sensors β and what the next generation of non-invasive monitors looks like.
Athletes, musicians and actors with diabetes share the devices, apps, and strategies that keep their blood sugar stable through demanding schedules.
A new generation of apps is helping patients track GLP-1 drug effects, diet, and side effects β with algorithms that personalize dosing recommendations.
Machine learning algorithms analyzing CGM data, dietary logs, and activity patterns are delivering personalized coaching that outperforms standard care in trials.
Leading endocrinologist Dr. Robert Kushner evaluates the evidence for telehealth diabetes management β when it works, when it doesn't, and what to look for in a platform.
When blood sugar crashes, seconds matter. A guide to glucose gels, tablets, and apps that track hypoglycemia patterns and alert caregivers automatically.
The pandemic forced diabetes care online at scale β and patients reported better medication adherence and fewer missed appointments. What to preserve going forward.
The triglyceride-glucose index, now deployable via smartphone apps, is emerging as a powerful predictor of macrovascular complications in Type 2 diabetes.
No articles match your search. Try different keywords or clear the filter.